Phase 2 Study to Assess the Safety and Efficacy of ANG003
for Exocrine Pancreatic Insufficiency (EPI)
26 locations incl. Long Beach
Sponsor: Anagram Therapeutics, Inc.
Sex: All·Age: 12+
Code: NCT07450547·Phase 2·Recruiting·Listed Mar 2026
University of Pittsburgh Medical Center
Clinical research site in Pittsburgh, Pennsylvania · 200 LOTHROP ST, 933 W MONTEFIORE, PITTSBURGH, PA 15213-2536 · (412) 692-4834 · Website
Part of University of Pittsburgh Medical Center
As of July 2026, 119 paid clinical trials are recruiting at University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania. Active studies at this site cover conditions such as Chronic Pancreatitis, Cystic Fibrosis and Advanced Solid Tumor. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at University of Pittsburgh Medical Center (119)
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
34 locations incl. Goodyear
Sponsor: Amgen
Sex: Male·Age: 18+
Code: NCT07213674·Phase 3·Recruiting·Listed Oct 2025
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
for Atrial Fibrillation (AF)
20 locations incl. Birmingham
Sponsor: Boston Scientific Corporation
Sex: All·Age: 18+
Code: NCT07187115·Recruiting·Listed Sep 2025
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
for COVID-19 Infection
65 locations incl. Canoga Park
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07013474·Phase 3·Recruiting·Listed Jun 2025
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
for Moderate Aortic Valve Stenosis
69 locations incl. Birmingham
Sponsor: Kardigan, Inc.
Sex: All·Age: 50+
Code: NCT07001800·Phase 2, Phase 3·Recruiting·Listed Jun 2025
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
for Atopic Dermatitis
66 locations incl. Birmingham
Sponsor: AbbVie
Sex: All·Age: 18 - 63
Code: NCT06389136·Phase 3·Recruiting·Listed Apr 2024
Assessment of CCM in HF With Higher Ejection Fraction
for Heart Failure
76 locations incl. Birmingham
Sponsor: Impulse Dynamics
Sex: All·Age: 18+
Code: NCT05064709·Recruiting·Listed Oct 2021
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD
for Chronic Obstructive Pulmonary Disease
54 locations incl. Dothan
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Sex: All·Age: 40 - 80
Code: NCT07016412·Phase 2·Recruiting·Listed Jun 2025
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
for Urinary Bladder Neoplasms
41 locations incl. Tucson
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT05614739·Phase 1·Recruiting·Listed Nov 2022
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
for Leukemia, Myeloid, Acute
51 locations incl. Birmingham
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06852222·Phase 3·Recruiting·Listed Feb 2025
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
for Multiple Myeloma
28 locations incl. Phoenix
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT05201781·Phase 4·Recruiting·Listed Jan 2022
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
for Antineutrophil Cytoplasmic Antibody-associated Vasculitis
57 locations incl. Scottsdale
Sponsor: Amgen
Sex: All·Age: 18 - 100
Code: NCT06072482·Phase 4·Recruiting·Listed Oct 2023
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
for Interstitial Lung Diseases
33 locations incl. Birmingham
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06806592·Phase 3·Recruiting·Listed Feb 2025
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
for Abdominal Aortic Aneurysm
28 locations incl. Loma Linda
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 20+
Code: NCT05378347·Recruiting·Listed May 2022
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
for Advanced Solid Tumor
31 locations incl. La Jolla
Sponsor: PMV Pharmaceuticals, Inc
Sex: All·Age: 12+
Code: NCT04585750·Phase 1, Phase 2·Recruiting·Listed Oct 2020
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
for Prostate Cancer
23 locations incl. Duarte
Sponsor: Amgen
Sex: Male·Age: 18+
Code: NCT04221542·Phase 1·Recruiting·Listed Jan 2020
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
for Non-muscle Invasive Bladder Cancer
33 locations incl. Homewood
Sponsor: Protara Therapeutics
Sex: All·Age: 18+
Code: NCT05951179·Phase 2·Recruiting·Listed Jul 2023
Nectero EAST System Clinical Study
for Abdominal Aortic Aneurysm
33 locations incl. Scottsdale
Sponsor: Nectero Medical, Inc.
Sex: All·Age: 21 - 85
Code: NCT06001918·Phase 2, Phase 3·Recruiting·Listed Aug 2023
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
for Functional Mitral Regurgitation
51 locations incl. Gilbert
Sponsor: Cardiac Dimensions, Inc.
Sex: All·Age: 18+
Code: NCT03142152·Recruiting·Listed May 2017
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
for Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
37 locations incl. Tucson
Sponsor: Intellia Therapeutics
Sex: All·Age: 18 - 90
Code: NCT06128629·Phase 3·Recruiting·Listed Nov 2023
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
for Venous Thromboses
25 locations incl. Stanford
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT05489588·Recruiting·Listed Aug 2022
Zenith® Fenestrated+ Clinical Study
for Aortic Aneurysm, Abdominal
30 locations incl. Birmingham
Sponsor: Cook Research Incorporated
Sex: All·Age: 18+
Code: NCT04875429·Recruiting·Listed May 2021
US National OCS Heart Perfusion (OHP) Registry
for Heart Transplant
37 locations incl. Phoenix
Sponsor: TransMedics
Sex: All·Age: All ages
Code: NCT05915299·Recruiting·Listed Jun 2023
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
for Spinal Muscular Atrophy (SMA)
42 locations incl. Phoenix
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: All ages
Code: NCT04174157·Recruiting·Listed Nov 2019
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
for Locally Advanced Pancreatic Cancer
15 locations incl. Sacramento
Sponsor: RenovoRx
Sex: All·Age: 18+
Code: NCT03257033·Phase 3·Recruiting·Listed Aug 2017
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
for Traumatic Brain Injury
12 locations incl. Sacramento
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT07455136·Recruiting·Listed Mar 2026
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
for Stargardt Disease
12 locations incl. Phoenix
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 6+
Code: NCT07425574·Recruiting·Listed Feb 2026
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
for Asthma
17 locations incl. Tempe
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07219173·Phase 2·Recruiting·Listed Oct 2025
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
for Breast Neoplasms
16 locations incl. Duarte
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07114601·Phase 1·Recruiting·Listed Aug 2025
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
for Advanced Solid Tumor
18 locations incl. Phoenix
Sponsor: BioNTech SE
Sex: All·Age: 18+
Code: NCT07070232·Phase 1, Phase 2·Recruiting·Listed Jul 2025
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
23 locations incl. Phoenix
Sponsor: Syncromune, Inc.
Sex: Male·Age: 18+
Code: NCT06533644·Phase 2·Recruiting·Listed Aug 2024
Lead-212 PSV359 Therapy for Patients With Solid Tumors
for Pancreatic Ductal Adenocarcinoma
11 locations incl. Miami
Sponsor: Perspective Therapeutics
Sex: All·Age: 18 - 90
Code: NCT06710756·Phase 1, Phase 2·Recruiting·Listed Nov 2024
Onyx™ Liquid Embolic IDE Clinical Study
for Peripheral Arterial Hemorrhage
18 locations incl. Phoenix
Sponsor: Medtronic Endovascular
Sex: All·Age: 22+
Code: NCT06742801·Recruiting·Listed Dec 2024
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
for Acute Respiratory Distress Syndrome
14 locations incl. Los Angeles
Sponsor: BioAegis Therapeutics Inc.
Sex: All·Age: 18+
Code: NCT05947955·Phase 2·Recruiting·Listed Jul 2023
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
for Familial Adenomatous Polyposis (FAP)
18 locations incl. Arcadia
Sponsor: Rapamycin Holdings Inc.
Sex: All·Age: 18+
Code: NCT06950385·Phase 3·Recruiting·Listed Apr 2025
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
for Generalized Myasthenia Gravis
24 locations incl. Phoenix
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 75
Code: NCT06744920·Phase 3·Recruiting·Listed Dec 2024
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
for Refractory Cancer
13 locations incl. Stanford
Sponsor: Immatics US, Inc.
Sex: All·Age: 18+
Code: NCT03686124·Phase 1, Phase 2·Recruiting·Listed Sep 2018
Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
for Advanced Solid Tumors
11 locations incl. San Diego
Sponsor: Pyxis Oncology, Inc
Sex: All·Age: 18+
Code: NCT06795412·Phase 1, Phase 2·Recruiting·Listed Jan 2025
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
for COPD
18 locations incl. Birmingham
Sponsor: Apreo Health, Inc.
Sex: All·Age: 40 - 84
Code: NCT06891755·Recruiting·Listed Mar 2025
Device Global Registry for the IlluminOss Bone Stabilization System
for Traumatic Fracture
10 locations incl. Los Angeles
Sponsor: IlluminOss Medical, Inc.
Sex: All·Age: 50+
Code: NCT05206981·Recruiting·Listed Jan 2022
Showing the 40 most relevant of 119 recruiting trials at this site. Browse all with filters →
More research sites in Pittsburgh
- University of Pittsburgh (157 trials)
- University of Pittsburgh Cancer Institute (UPCI) (86 trials)
- UPMC Hillman Cancer Center (78 trials)
- Allegheny General Hospital (64 trials)
- Children's Hospital of Pittsburgh of UPMC (61 trials)
- UPMC Children's Hospital of Pittsburgh (51 trials)
- UPMC-Passavant Hospital (35 trials)
- Allegheny Health Network (31 trials)
- UPMC-Saint Clair Hospital Cancer Center (28 trials)
- UPMC-Saint Margaret (25 trials)
Explore more
Paid clinical trials in Pittsburgh, PA · Pennsylvania clinical trials